BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 26628469)

  • 1. Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States.
    Murphy CT; Galloway TJ; Handorf EA; Egleston BL; Wang LS; Mehra R; Flieder DB; Ridge JA
    J Clin Oncol; 2016 Jan; 34(2):169-78. PubMed ID: 26628469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased pathologic upstaging with rising time to treatment initiation for head and neck cancer: A mechanism for increased mortality.
    Xiao R; Ward MC; Yang K; Adelstein DJ; Koyfman SA; Prendes BL; Burkey BB
    Cancer; 2018 Apr; 124(7):1400-1414. PubMed ID: 29315499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing time to treatment initiation for head and neck cancer: an analysis of the National Cancer Database.
    Murphy CT; Galloway TJ; Handorf EA; Wang L; Mehra R; Flieder DB; Ridge JA
    Cancer; 2015 Apr; 121(8):1204-13. PubMed ID: 25490875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of adjuvant chemoradiotherapy timing on survival of head and neck cancers.
    Tam M; Wu SP; Gerber NK; Lee A; Schreiber D; Givi B; Hu K
    Laryngoscope; 2018 Oct; 128(10):2326-2332. PubMed ID: 29481712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment delays in oral cavity squamous cell carcinoma and association with survival.
    Fujiwara RJ; Judson BL; Yarbrough WG; Husain Z; Mehra S
    Head Neck; 2017 Apr; 39(4):639-646. PubMed ID: 28236349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No impact of time to treatment initiation for head and neck cancer in a tertiary university center in 2003, 2008 and 2013.
    Kouka M; Engelhardt M; Wittig A; Schultze-Mosgau S; Ernst T; Guntinas-Lichius O
    Eur Arch Otorhinolaryngol; 2022 Sep; 279(9):4549-4560. PubMed ID: 35488907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival outcomes with concurrent chemoradiation for elderly patients with locally advanced head and neck cancer according to the National Cancer Data Base.
    Amini A; Jones BL; McDermott JD; Serracino HS; Jimeno A; Raben D; Ghosh D; Bowles DW; Karam SD
    Cancer; 2016 May; 122(10):1533-43. PubMed ID: 26969811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effects of Time to Treatment Initiation for Patients With Non-small-cell Lung Cancer in the United States.
    Cushman TR; Jones B; Akhavan D; Rusthoven CG; Verma V; Salgia R; Sedrak M; Massarelli E; Welsh JW; Amini A
    Clin Lung Cancer; 2021 Jan; 22(1):e84-e97. PubMed ID: 33039348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival and overall treatment time after postoperative radio(chemo)therapy in patients with head and neck cancer.
    Tribius S; Donner J; Pazdyka H; Münscher A; Gröbe A; Petersen C; Krüll A; Tennstedt P
    Head Neck; 2016 Jul; 38(7):1058-65. PubMed ID: 26873810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer.
    Graboyes EM; Garrett-Mayer E; Ellis MA; Sharma AK; Wahlquist AE; Lentsch EJ; Nussenbaum B; Day TA
    Cancer; 2017 Dec; 123(24):4841-4850. PubMed ID: 28841234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of time to treatment initiation for patients with oral cavity squamous cell carcinoma: a population-based, retrospective study.
    Jensen JS; Jakobsen KK; Mirian C; Ghanizada M; Håkansson K; Wessel I; Grønhøj C; Rasmussen JH; von Buchwald C
    Acta Oncol; 2021 Apr; 60(4):491-496. PubMed ID: 33356698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of time to treatment initiation on survival from head and neck cancer in north-eastern Italy.
    Polesel J; Furlan C; Birri S; Giacomarra V; Vaccher E; Grando G; Gobitti C; Navarria F; Schioppa O; Minatel E; Bidoli E; Barzan L; Franchin G
    Oral Oncol; 2017 Apr; 67():175-182. PubMed ID: 28351574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer.
    David JM; Ho AS; Luu M; Yoshida EJ; Kim S; Mita AC; Scher KS; Shiao SL; Tighiouart M; Zumsteg ZS
    Cancer; 2017 Oct; 123(20):3933-3942. PubMed ID: 28640546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of adjuvant treatment and primary anatomical site in head and neck basaloid squamous cell carcinoma survival: an analysis of the National Cancer Database.
    Gootee J; Patel M; Aurit S; Silberstein P
    Clin Transl Oncol; 2020 Dec; 22(12):2264-2274. PubMed ID: 32440914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node ratio as a prognostic factor in head and neck cancer patients.
    Chen CC; Lin JC; Chen KW
    Radiat Oncol; 2015 Aug; 10():181. PubMed ID: 26302761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Delay in Treatment Initiation on Overall Survival in Laryngeal Cancers.
    Kompelli AR; Li H; Neskey DM
    Otolaryngol Head Neck Surg; 2019 Apr; 160(4):651-657. PubMed ID: 30322343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
    Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
    Fakhry C; Westra WH; Li S; Cmelak A; Ridge JA; Pinto H; Forastiere A; Gillison ML
    J Natl Cancer Inst; 2008 Feb; 100(4):261-9. PubMed ID: 18270337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase III randomized trial of preoperative concurrent chemoradiotherapy versus preoperative radiotherapy for patients with locally advanced head and neck squamous cell carcinoma.
    Yi J; Huang X; Xu Z; Liu S; Wang X; He X; Luo D; Luo J; Xiao J; Zhang S; Wang K; Qu Y; Tang Y; Liu W; Xu G; Gao L; Wang D
    Oncotarget; 2017 Jul; 8(27):44842-44850. PubMed ID: 28179586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival impact of waiting time for radical radiotherapy in nasopharyngeal carcinoma: A large institution-based cohort study from an endemic area.
    Liang H; Xiang YQ; Lv X; Xie CQ; Cao SM; Wang L; Qian CN; Yang J; Ye YF; Gan F; Ke LR; Yu YH; Liu GY; Qiu WZ; Huang XJ; Wen CH; You N; Wang XQ; Guo X; Xia WX
    Eur J Cancer; 2017 Mar; 73():48-60. PubMed ID: 28161498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.